J Dent Rehabil Appl Sci.  2017 Sep;33(3):230-237. 10.14368/jdras.2017.33.3.230.

Additional use of autogenous periosteal barrier membrane combined with regenerative therapy in the interproximal intrabony defects: case series

• Kim HJ
• Kim HM
• Lee JY

• KMID: 2394647
• DOI: http://doi.org/10.14368/jdras.2017.33.3.230

Abstract

Regenerative therapy in an interproximal intrabony defect is a challenge due to unaesthetic appearance after surgery. In this article, we introduce a case series of additional use of autogenous periosteal barrier membrane combined with bovine bone mineral and enamel matrix derivative (EMD) in interproximal periodontal intrabony defects to overcome an aforementioned shortcoming. During the periodontal regenerative surgery, autogenous periosteal membrane was additionally adopted besides xenograft material and EMD. Clinical and radiographic examinations were performed before surgery and 6 months after surgical treatment. All clinical parameters were improved and the intrabony defects were resolved on the radiography 6 months after surgery. Moreover, soft tissue esthetics such as the contour of interdental papilla was better than that of conventional regenerative therapy. Periodontal regenerative therapy using several graft materials and bioactive materials was effective in the treatment of periodontal intrabony defect. Moreover, using of autogenous periosteal barrier membrane combined with xenograft and EMD has additional effect for the treatment of an interproximal intrabony defect in terms of augmentation of interdental soft tissue volume.

Keyword

enamel matrix proteins; guided tissue regeneration; periosteum

MeSH Terms

Dental Enamel
Esthetics
Gingiva
Guided Tissue Regeneration
Heterografts
Membranes*
Miners
Periosteum
Radiography
Transplants

Figure

• 

  Fig. 1 Regenerative surgical sequence with additional use of autogenous periosteal membrane graft combined with xenograft and Emdogain®. (A) Baseline PPD 7 mm and recession 2 mm. (B) After flap reflection, 2-wall intrabony defect with 6 mm depth. (C) Autogenous periosteal membrane graft combined with xenograft and Emdogain®. (D) Primary closure of the overlying flap.

• 

  Fig. 2 Periapical radiograph before surgery (A, B, C) and 6 months after surgery (D, E, F). Note the resolution of intrabony defect after surgery (D, E, F).

• 

  Fig. 3 Clinical presentation of 3 cases. Preoperative view (A, B, C) and 6 months after regenerative surgery (D, E, F). Note the augmentation of the volume of the interdental papilla after surgery (D, E, F).

Reference

References

1. Claffey N, Egelberg J. Clinical indicators of probing attachment loss following initial periodontal treatment in advanced periodontitis patients. J Clin Periodontol. 1995; 22:690–6. DOI: 10.1111/j.1600-051X.1995.tb00828.x. PMID: 7593699.

2. Matuliene G, Pjetursson BE, Salvi GE, Schmidlin K, Brägger U, Zwahlen M, Lang NP. Influence of residual pockets on progression of periodontitis and tooth loss: results after 11 years of maintenance. J Clin Periodontol. 2008; 35:685–95. DOI: 10.1111/j.1600-051X.2008.01245.x. PMID: 18549447.

3. Papapanou PN, Wennström JL. The angular bony defect as indicator of further alveolar bone loss. J Clin Periodontol. 1991; 18:317–22. DOI: 10.1111/j.1600-051X.1991.tb00435.x. PMID: 2066446.

4. Papapanou PN, Tonetti MS. Diagnosis and epidemiology of periodontal osseous lesions. Periodontol 2000. 2000; 22:8–21. DOI: 10.1034/j.1600-0757.2000.2220102.x.

5. Cortellini P, Labriola A, Tonetti MS. Regenerative periodontal therapy in intrabony defects: state of the art. Minerva Stomatol. 2007; 56:519–39. PMID: 18091668.

6. Cortellini P, Tonetti MS. A minimally invasive surgical technique with an enamel matrix derivative in the regenerative treatment of intra-bony defects: a novel approach to limit morbidity. J Clin Periodontol. 2007; 34:87–93. DOI: 10.1111/j.1600-051X.2007.01144.x. PMID: 17243998.

7. Sculean A, Nikolidakis D, Nikou G, Ivanovic A, Chapple IL, Stavropoulos A. Biomaterials for promoting periodontal regeneration in human intrabony defects: a systematic review. Periodontol 2000. 2015; 68:182–216. DOI: 10.1111/prd.12086. PMID: 25867987.

8. Esposito M, Grusovin MG, Papanikolaou N, Coulthard P, Worthington HV. Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects. A Cochrane systematic review. Eur J Oral Implantol. 2009; 2:247–66. PMID: 20467602.

9. Kao RT, Nares S, Reynolds MA. Periodontal regeneration - intrabony defects: a systematic review from the AAP Regeneration Workshop. J Periodontol. 2015; 86:S77–104. DOI: 10.1902/jop.2015.130685. PMID: 25216204.

10. Lekovic V, Camargo PM, Weinlaender M, Nedic M, Aleksic Z, Kenney EB. A comparison between enamel matrix proteins used alone or in combination with bovine porous bone mineral in the treatment of intrabony periodontal defects in humans. J Periodontol. 2000; 71:1110–6. DOI: 10.1902/jop.2000.71.7.1110. PMID: 10960017.

11. Cortellini P, Prato GP, Tonetti MS. The simplified papilla preservation flap. A novel surgical approach for the management of soft tissues in regenerative procedures. Int J Periodontics Restorative Dent. 1999; 19:589–99. PMID: 10815597.

12. Saimbi CS, Gautam A, Khan MA, Nandlal . Periosteum as a barrier membrane in the treatment of intrabony defect: a new technique. J Indian Soc Periodontol. 2014; 18:331–5. DOI: 10.4103/0972-124X.134571. PMID: 25024547. PMCID: PMC4095626.

13. Lekovic V, Kenney EB, Carranza FA, Martignoni M. The use of autogenous periosteal grafts as barriers for the treatment of Class II furcation involvements in lower molars. J Periodontol. 1991; 62:775–80. DOI: 10.1902/jop.1991.62.12.775. PMID: 1765940.

14. Trombelli L, Simonelli A, Pramstraller M, Wikesjö UM, Farina R. Single flap approach with and without guided tissue regeneration and a hydroxyapatite biomaterial in the management of intraosseous periodontal defects. J Periodontol. 2010; 81:1256–63. DOI: 10.1902/jop.2010.100113. PMID: 20528696.

15. Rakmanee T, Griffiths GS, Auplish G, Darbar U, Petrie A, Olsen I, Donos N. Treatment of intrabony defects with guided tissue regeneration in aggressive periodontitis: clinical outcomes at 6 and 12 months. Clin Oral Investig. 2016; 20:1217–25. DOI: 10.1007/s00784-015-1608-z. DOI: 10.1007/s00784-015-1609-y.

16. Machtei EE. The effect of membrane exposure on the outcome of regenerative procedures in humans: a meta-analysis. J Periodontol. 2001; 72:512–6. DOI: 10.1902/jop.2001.72.4.512. PMID: 11338304.

17. Kwan SK, Lekovic V, Camargo PM, Klokkevold PR, Kenney EB, Nedic M, Dimitrijevic B. The use of autogenous periosteal grafts as barriers for the treatment of intrabony defects in humans. J Periodontol. 1998; 69:1203–9. DOI: 10.1902/jop.1998.69.11.1203. PMID: 9848529.

18. Gamal AY, Mailhot JM. A novel marginal periosteal pedicle graft as an autogenous guided tissue membrane for the treatment of intrabony periodontal defects. J Int Acad Periodontol. 2008; 10:106–17. PMID: 19055224.

19. Tonetti MS, Prato GP, Cortellini P. Factors affecting the healing response of intrabony defects following guided tissue regeneration and access flap surgery. J Clin Periodontol. 1996; 23:548–56. DOI: 10.1111/j.1600-051X.1996.tb01823.x. PMID: 8811474.